We would like to express our sincere gratitude for your continued patronage.
Regarding the recent reported fatal accident involving regenerative medicine (stem cell administration), we would like to express our deepest condolences to the deceased and their family. The reported accident occurred at a different medical institution than ours. We hope that patients can rest assured. The Ministry of Health,
Labor and Welfare is currently investigating the cause, and details have yet to be released. Our hospital is not in a position to evaluate or assign responsibility to individual medical institutions, and we believe that we must await the clarification of the facts. Meanwhile, we will continue to prioritize patient peace of mind and strive for even more thorough safety management.
Since the introduction of regenerative medicine at our hospital, we have required patients to submit a pre-treatment health check to appropriately assess the risks associated with stem cell administration. This is an essential process for ensuring patient safety, and we apologize for any inconvenience this may cause. However, we appreciate your continued cooperation.
Furthermore, particular attention is required in stem cell therapy to ensure quality control during cell delivery. Because cells are extremely delicate, temperature disturbances during transportation pose a risk to their safety.
For this reason, our hospital has maintained an in-house laboratory (a facility for culturing and testing cells) since the beginning of our regenerative medicine program. By completing all processes in-house, we eliminate the risks associated with transportation and are able to provide treatment under safer conditions. We also conduct strict checks based on national and international standards, and, when necessary, seek confirmation from external organizations to ensure patient safety. Following
this incident, our hospital immediately conducted an emergency inspection and reconfirmed our safety measures. We are also collaborating with external experts to strengthen our safety system to even stricter standards.
We will also respond honestly to any questions so that not only patients receiving treatment but also their families can feel at ease. If you have any concerns, please feel free to contact us.
We take this incident seriously and will fulfill our responsibility to protect the potential and safety of regenerative medicine. We will continue to prioritize the lives and health of our patients and build a better future for healthcare by providing trusted medical care.
September 1, 2025
Medical Corporation HELENE
Omotesando Helene Clinic/Helene Ao Building Clinic
Our Hospital's Approach to Stem Cells
We would like to express our sincere gratitude for your continued patronage.
Regarding the recent reported fatal accident involving regenerative medicine (stem cell administration), we would like to express our deepest condolences to the deceased and their family. The reported accident occurred at a different medical institution than ours. We hope that patients can rest assured. The Ministry of Health,
Labor and Welfare is currently investigating the cause, and details have yet to be released. Our hospital is not in a position to evaluate or assign responsibility to individual medical institutions, and we believe that we must await the clarification of the facts. Meanwhile, we will continue to prioritize patient peace of mind and strive for even more thorough safety management.
Since the introduction of regenerative medicine at our hospital, we have required patients to submit a pre-treatment health check to appropriately assess the risks associated with stem cell administration. This is an essential process for ensuring patient safety, and we apologize for any inconvenience this may cause. However, we appreciate your continued cooperation.
Furthermore, particular attention is required in stem cell therapy to ensure quality control during cell delivery. Because cells are extremely delicate, temperature disturbances during transportation pose a risk to their safety.
For this reason, our hospital has maintained an in-house laboratory (a facility for culturing and testing cells) since the beginning of our regenerative medicine program. By completing all processes in-house, we eliminate the risks associated with transportation and are able to provide treatment under safer conditions. We also conduct strict checks based on national and international standards, and, when necessary, seek confirmation from external organizations to ensure patient safety. Following
this incident, our hospital immediately conducted an emergency inspection and reconfirmed our safety measures. We are also collaborating with external experts to strengthen our safety system to even stricter standards.
We will also respond honestly to any questions so that not only patients receiving treatment but also their families can feel at ease. If you have any concerns, please feel free to contact us.
We take this incident seriously and will fulfill our responsibility to protect the potential and safety of regenerative medicine. We will continue to prioritize the lives and health of our patients and build a better future for healthcare by providing trusted medical care.
September 1, 2025
Medical Corporation HELENE
Omotesando Helene Clinic/Helene Ao Building Clinic
